The media recently reported that the FDA had issued a stern warning to Abbott for failing to properly investigate and resolve cybersecurity risks and battery malfunctions for its pacemaker and defibrillator devices:
In response, IoT cybersecurity expert Rod Schultz, VP of Product, Rubicon Labs, says: "The FDA warning to Abbott is an echo of challenges we’ve seen in other technology verticals that are built with batteries and software. Every mobile device in the field today is available and affordable because of advances in those two areas. The healthcare industry must build on technology advancement to innovate, but patient safety and FDA requirements have got to be addressed as top-most priorities. The FDA works closely with federal agencies, DHS, and medical device manufacturers to increase reliability and security, but it seems that more guidance is needed, and perhaps the incentive structure needs to be changed.
- SECURITY EXPERT
- Talking Point
- Posted On
